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Today, it is necessary to identify relevant compounds appearing in discovery and develop-
ment of new drug substances in the pharmaceutical industry. For that purpose, the measure-
ment of accurate molecular mass and empirical formula calculation is very important for
structure elucidation in addition to other available analytical methods. In this work, the
identification and confirmation of degradation products in a finished dosage form of the
antibiotic drug amoxicillin obtained under stress conditions will be demonstrated. Structure
elucidation is performed utilizing liquid chromatography (LC) ion trap MS/MS and MS3
together with accurate mass measurement of the molecular ions and of the collision induced
dissociation (CID) fragments by liquid chromatography electro spray ionization time-of-flight
mass spectrometry (LC/ESI-TOF). (J Am Soc Mass Spectrom 2005, 16, 1670–1676) © 2005
American Society for Mass SpectrometryIn modern pharmaceutical drug discovery and de-velopment, it is of crucial importance to identifyunknown compounds with the highest possible con-
fidence because of their potential pharmacologic effects
on humans. Such compounds could be, for instance, the
pharmaceutically active substances themselves, minor
byproducts emerging during the production process,
secondary substances in drugs isolated from a natural
source, metabolites created in the human body, or
degradation products of the pharmaceutical agent aris-
ing during storage. In addition to the repertoire of
analytical methods for structure elucidation, the mass
spectrometric measurement of accurate molecular mass
and, consequently, the determination of the empirical
formula is a common strategy for the identification of
unknown compounds. Until a few years ago, the only
instruments available to perform these measurements
with highest mass accuracy were the magnetic sector
mass spectrometers. Nowadays, ESI orthogonal accel-
eration TOF (oaTOF) instruments are also capable of
handling this task sufficiently for compound confirma-
tion. This is demonstrated by a comparison study of
different types of mass spectrometer instruments for the
determination of accurate masses of small molecules
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doi:10.1016/j.jasms.2005.06.002[1]. The improved molecular mass determination capa-
bility of oaTOF instruments was made possible by
several technical innovations in TOF technology intro-
duced during the past few years. One of the main
technical improvements is the development of orthog-
onal acceleration (oa) TOF technology, which decouples
ion beam velocity spread from the TOF axis and there-
fore provides better resolution [2]. In such an environ-
ment, today’s routine of coupling continuous ionization
sources like the electrospray ionization (ESI) source
with oaTOF mass analyzers is of special importance for
LC/ESI-TOF applications. High mass accuracy is only
achieved when a reference compound, e.g., a reference
mass solution, is simultaneously introduced into the
mass spectrometer. However, mixing the LC column
effluent with a stream of reference material can result in
ion suppression, discrimination, or adduct formation.
To preclude the need for mixing the analyte and the
reference compound before spray ionization, a dual
sprayer interface is used for ESI [3, 4]. Such an instru-
ment is capable of achieving resolving powers of better
than 15,000 and mass accuracies in the low single digit
ppm range for small molecules [1]. Recently, the imple-
mentation of oaTOF instruments for the measurement
of accurate molecular mass, the calculation of the em-
pirical formula, and consequently, the identity confir-
mation of an unknown compound, was impressively
demonstrated for a large number of published applica-
tions [5–10]. For instance, LC/ESI oaTOF was used for
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accurate mass measurement of the molecular ion and
the CID fragments [5, 6]. The instrument found its place
for the quantification and accurate mass measurement
of pharmaceutical drugs in plasma [7] as well as for the
characterization of trace level impurities in a drug
substance [8]. In conjunction with an ion trap instru-
ment for MS/MS and MS3 experiments to gain struc-
tural information, the ESI oaTOF was used for the
identification of a photooxygenation product of a broad
spectrum antibiotic used for live stock [9] and for the
identification of highly complex polyene macrolides
isolated from Streptomyces noursei by means of an ion
trap monitored purification process [10].
The identification of degradation products from antibi-
otics like amoxicillin is a known analytical method by
LC/UV and LC/single quadrupole mass spectrometry
[11]. In this work, the identification of degradation prod-
ucts from the antibiotic drug amoxicillin obtained under
stability test conditions will be demonstrated by means of
an instrument combination not utilized before. This task
will be solved by a combination of structure elucidation
using an LC ion trap with MS/MS and MS 3 and accurate
mass measurement using ESI oaTOF. Both sets of data are
combined and used to construct a degradation pathway of
amoxicillin under the applied stress conditions. Besides
antibiotics, the mass spectrometric approach described in
this article can also be applied for many drugs belonging
to other chemical classes than penicillin to identify degra-




The ESI ion trap and the ESI oaTOF MS analyses were
performed with the Agilent 1100 series LC/MSD XCT
ion trap and with the Agilent LC/MSD TOF (Agilent
Technologies, Santa Clara, CA), which was equippedwith
a dual sprayer source for the simultaneous but separate
infusion of the reference mass solution with LC eluent.
The LC system used was an Agilent 1100 series capillary
LC system (Agilent Technologies, Waldbronn, Germany)
consisting of a capillary pump with a micro vacuum
degasser, a temperature controlled micro well-plate au-
tosampler and a column compartment. The column used
was a Zorbax SB Aq, 0.3 mm x 150 mm, 3.5 m. The
software used for instrument control was Agilent Chem-
Station A10.02 (Agilent Technologies, Wilmington, DE),
ion trap software 5.2, and TOF software A01. Data analy-
sis was performed using ion trap data analysis software
and Analyst QS for ESI TOF data.
Methods
The Agilent 1100 capillary pump was operated under
the following conditions: Solvent A: water, 10 mM
ammonium formate, pH 4.1; Solvent B: ACN. Columnflow: 8 L/min, primary flow: 500–800 L/min. Gra-
dient: 0 min 0% B, 1 min 0% B, 13 min 25% B, 23 min
25% B. Stop time: 23 min. Post time: 15 min. The Agilent
1100 autosampler was used to make injections of 1 L
and the samples were maintained at 4 °C. The sample
loop was switched to bypass after 1 min to reduce delay
volume.
The mass spectrometers were operated under the
following conditions:
(1) Ion trap MS: source: ESI in positive mode; drying
gas: 5.0 L/min; gas temperature: 300 °C; nebulizer: 15
psi; ion current control: 150,000; maximum accumula-
tion time: 50 ms; scan: 200–600. For the acquisition of
MS/MS and MS3 the automated data dependent acqui-
sition functionality was used.
(2) ESI oaTOF MS: source: ESI in positive mode with
dual sprayer; drying gas: 7.0 L/min; gas temperature:
300 °C; nebulizer: 15 psi; scan: 50–1000; fragmentor: 150
or 300 V for CID; skimmer: 60 V; capillary: 5000 V.
Sample Preparation
The antibiotic amoxicillin was stressed under acidic con-
ditions. Approximately 1 mL of amoxicillin solution (25
mg/mL inDMSO)was added to 1mL 0.1MHCl solution.
The sample was stirred for 1 h at room temperature (RT
25 °C) and then diluted (1:10 with DMSO).
Results and Discussion
The degradation of amoxicillin (1) was induced by
subjecting the pure drug substance to harsh acidic
conditions, as described in the experimental section.
Aliquots of this solution were collected at various time
points and subjected to capillary chromatography to
separate the accumulated degradation products. The
base peak chromatogram (BPC) clearly shows the deg-
radation of amoxicillin into various products (Figure 1).
The degradation products were identified by structure
elucidation of the molecular ions and the CID frag-
ments using ion trap MS/MS and MS3 experiments.
Identity confirmation was provided by accurate mass
determination using ESI oaTOF MS to deduce molecu-
lar formulae. The extracted ion chromatogram (EIC) for
Figure 1. BPC of amoxicillin (1) and its degradation products
after acid exposure.
1672 NA¨GELE AND MORITZ J Am Soc Mass Spectrom 2005, 16, 1670–1676Figure 2. Ion Trap MS/MS and MS3 analysis of amoxicillin (1) and its degradation products after
acidic exposure. (a) Amoxicillin (1) (C16H19N3O5S), [M  H]
  m/z 366.1. (b) Amoxicillin penicilloic
acid (2) (C16H21N3O6S), [MH]
 m/z 384.1 (c) Amoxicillin penilloic acid I and II (3) (C15H21N3O4S),
[M  H]  m/z 340.1 (d) Diketopiperazine amoxicillin (4) (C H N O S), [M  H]  m/z 366.1. (e)16 19 3 5
4-Hydroxyphenylglycyl amoxicillin (5) (C24H26N4O7S), [M  H]
  m/z 515.1.
n pa
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tion time of 4.0 min for amoxicillin (1) and 10.5 min for
the isomeric compound (4). This mass spectrum
showed a potassium adduct at m/z 404.0 and a product
generated by the loss of ammonium at m/z 349.0. The
product ion from ammonia loss is also generated under
CID conditions in the ion trap as the major product in
the first stage of MS/MS (Figure 2a). In MS3, isolation
and fragmentation of the ion at m/z 349.0 results in two
ions at m/z 114.0 and at 160.0, which could be easily
assigned to the corresponding structural components
(Figures 2a). According to a fragmentation which could
not be assigned the ions at m/z 207 and 234 occur in this
spectrum. The degradation of amoxicillin (1) in an
acidic medium starts with the opening of the four-
membered -lactam ring and yields the product amoxi-
cillin penicilloic acid (2), which contains a free carbox-
ylic acid group and gives a higher polarity to this
molecule. This leads to a shift towards an earlier reten-
tion time in the reverse phase liquid chromatography
(RP LC) separation, which was seen in the EIC of
protonated amoxicillin penicilloic acid (2) at m/z 384.0
with a retention time at 2.6 min. The mass spectrum
shows the protonated molecular ion of (2) and also its
potassium adduct atm/z 422.0. The fragmentation of the
molecular ion (2) results in two product ions, one from
a loss of ammonia at m/z 367.1 and the other from
subsequent decarboxylation at m/z 323.1. This ion (m/z
323.1) is the precursor for the MS3 fragmentation, which
yields fragment ions at m/z 189.0 (fragmentation of the
amide bond) and at m/z 160.0, the thiazolidine ring
(Figure 2b).
Starting with Compound (2), there are two possible
pathways for further degradation. The first one is based
on the decarboxylation of the free carboxylic acid and
leads to the stereoisomeric compounds amoxicillin pe-
nilloic acid I and II (3). The second possible degradation
reaction of intermediate (2) is the formation of a new,
stable, six-membered ring giving diketopiperazine amoxi-
cillin (4). Both reaction products were identified in the
amoxicillin solution stored under acidic conditions. The
Figure 3. Degradatioprotonated stereo isomeric amoxicillin penilloic acids Iand II (3) both at m/z 340.2 were extracted from the BPC
at 6.7–7.3 and 8.5–9.0 min. They were detected as the
protonated species and as the potassium adducted
species at m/z 378.0. From the MS/MS analysis of the
protonated molecular ion, the product of a deamination
reaction is assigned. From the MS3 fragmentation of the
deamidation ion at m/z 323.1 a product is detected at
m/z 188.9 (Figure 2c). The MS, MS/MS and MS3 spectra
of the stereoisomer occurring at 8.5 min are identical to
those obtained for the isomer eluting at 6.7 min.
The second reaction product derived from com-
pound (2) the protonated diketopiperazine amoxicillin
(4) with a protonated molecular ion at m/z 366.0 was
extracted from the BPC and the corresponding peak
was seen in the EIC at a retention time of 10.4 min.
Additionally, the protonated form of the compound is
also accompanied by a potassium adduct giving a
positively charged ion at m/z 404.0. In the MS/MS
experiment, the molecule undergoes fragmentation by
cleavage of the bond between the six-membered dike-
topiperazine ring and the five-membered thiazolidine
ring yielding fragments at m/z 206.2 and 160.0, respec-
tively. Isolation and MS3 fragmentation of the ion at m/z
160.0 yields a product ion atm/z 114.1 obtained from the
cleavage of a carboxylic acid group from the thiazoli-
dine ring moiety (Figure 2d).
In another reaction pathway, amoxicillin (1) under-
goes a nucleophilic attack on itself, where the benzylic
carbonyl group is attacked by the free amino group to
form 4-hydroxyphenylglycyl amoxicillin (5). The pro-
tonated molecular ion at m/z 515.0 was seen in the
extracted ion chromatogram at 9.3 min. The MS spec-
trum showed the protonated molecular ion and the
potassium adduct atm/z 552.9. The MS/MS spectrum of
m/z 515.0 reveals a product at m/z 498.0 from a loss of
ammonia and also a product at m/z 339.1 from fragmen-
tation of the five-membered thiazolidine ring. The MS3
fragmentation on the ion at m/z 339.1 gave major ions at
m/z 311.1 (loss of a carbonyl group) and 122.1 (a
benzylic amino fragment) (Figure 2e). The complete
degradation pathway of amoxicillin (1) with the pro-
thway of amoxicillin.posed degradation products is summarized in Figure 3.
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mediates (Figure 3) involved in the degradation path-
way of amoxicillin (1), accurate mass measurement
were performed on an ESI oaTOF instrument connected
to a capillary LC for separation of the amoxicillin
degradation products. The experiment was performed
twice using different fragmentor voltages of 150 and
300 V in the oaTOF MS. At a fragmentor voltage of 150
V there is no CID observed whereas good fragmenta-
tion of the molecular ion from each of the separated
degradation products is observed at a voltage of 300 V
Figure 4. ESI oaTOF analysis of amoxicillin (1) a
accurate mass measurement and compound con
H]  m/z 366.1124. (b) Amoxicillin penicilloic a
Amoxicillin penilloic acid I and II (3) (C15H21N3O
amoxicillin (4) (C16H19N3O5S), [M  H]
  m/z
(C24H26N4O7S), [M  H]
  m/z 515.1600.(only these data are discussed below). The measuredmass (m/z) for protonated amoxicillin (1) is 366.1123,
which has a deviation of 0.1 mDa or 0.27 ppm from the
calculated molecular monoisotopic mass (Figure 4a).
For structural confirmation, fragmentation of amoxicil-
lin (1) is obtained by the application of an increased
fragmentor voltage up to 300 V (Figure 4a). The main
fragment shown in the mass spectrum is the loss of
ammonia at m/z 349.0859, which has a deviation from
the calculated mass of 0.1 mDa or 0.28 ppm. The
formula C6H10NO2S of the fragment at m/z 160.0435
obtained by the cleavage of the five-membered thiazo-
s degradation products after acidic exposure for
ation. (a) Amoxicillin (1) (C16H19N3O5S), [M 
2) (C16H21N3O6S), [M  H]
  m/z 384.1229. (c)
[M  H]  m/z 340.1331. (d) Diketopiperazine




366.1lidine ring from the molecular ion is calculated with a
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fragmentation is shown in Figure 4a. The mass accuracy
in mDa and the ppm value of the obtained molecular
ions and fragments calculated from the mean measured
mass of five experiments is shown in Table 1a. For more
detailed information about the masses measured in the
five experiments as well as the means and standard
deviations for the masses; mass accuracies in mDa and
ppm of each measured molecule and their correspond-
ing mean and standard deviation, see the Supplemen-
tary Material in the online version of the article. The
higher, but still acceptable, values for the mean and the
standard deviation of the fragment ion at m/z 114.0377
could be explained by the fact that this value is below
the lowest measured point of the calibration curve of
the instrument.
The first degradation product of amoxicillin (1) ob-
tained after breaking the four-membered -lactam ring is
amoxicillin penicilloic acid (2) and was confirmed by
accurate mass measurement at m/z 384.1225, with 1.04
ppm mass accuracy and formula calculation with the ESI
oaTOF at a fragmentor voltage of 300 V. The structure of
this degradation product was confirmed by the appear-
ance of the characteristic fragment at m/z 323.1063 with
0.93 ppm mass accuracy, which is the product of a
decarboxylation reaction. The complete fragmentation
pattern of amoxicillin penicilloic acid (2) also reveals
fragments at m/z 122.0606 and 189.0697, which are impor-
tant for the structure confirmation (Figure 4b). The com-
plete information obtained from the CID fragments of
amoxicillin penicilloic acid (2) is summarized in Table 1b
in the Supplementary Material with their molecular for-
mula and the measured mass accuracies based on the
mean mass measured in five experiments.
The subsequent degradation products obtained
from amoxicillin penicilloic acid (2) by a decarboxyl-
ation of the free carboxylic acid group are the stereoi-
someric amoxicillin penilloic acids I and II (3). Their
identity was confirmed by accurate mass measure-
ment and formula confirmation at m/z 340.1328
(C15H22N3O4S) with a deviation of 0.30 mDa or 0.89
ppm from the theoretical mass. The main fragment
ion obtained in the CID spectrum is the loss of
ammonia at m/z 323.1065 (Figure 4c). The same frag-
ment ion was also observed in the CID spectrum of
amoxicillin penicilloic acid (2) (Figure 4b) and gives
further evidence for the identity of the degradation
products amoxicillin penilloic acid I and II (3). The
identified fragmentation reactions and fragment ions
are outlined in Figure 4c and summarized in Table 1c.
The detailed table is again summarized in the Sup-
plementary Material online.
Beginning with amoxicillin penicilloic acid (2), the
degradation pathway also leads to diketopiperazine
amoxicillin (4) by the formation of a six-membered
ring structure (Figure 3). The molecular formula
C16H19N3O5S was confirmed by accurate mass mea-
surement with the ESI oaTOF at m/z 366.1125 with
0.27 ppm accuracy. The main CID fragment belongsto a cleavage of the molecule at the bond between the
two rings with the charge remaining with the five-
membered thiazolidine ring at m/z 160.0428 with a
mass accuracy of 2.65 ppm (Figure 4d). The con-
firmed fragmentation is shown in Figure 4d and the
mean measured masses of the fragments and their
calculated accuracies are summarized in Table 1d in
the Supplementary Material.
Finally, the identity of the product obtained from a
self-condensation reaction of amoxicillin (1) to
4-hydroxyphenylglycyl amoxicillin (5) was confirmed
by using the ESI oaTOF instrument. The protonated
molecular ion at m/z 516.1596 with the calculated for-
mula C24H27N4O7S was confirmed with a mass accu-
racy of 0.77 ppm. The CID fragments useful for the
identification come from loss of ammonia (m/z 498.1333), a
loss of the five-membered thiazolidine ring from the
parent molecule and from a residual benzyl imminium
ion (m/z 122.0605) (Figure 4e), which show accuracies of
0.40 and 0.82 ppm, respectively. The mean masses of the
fragment ions and the molecular ion are determined with
sufficient accuracy for unambiguous identification of the
fragments and consequently the molecule (Table 1e, see
Supplementary Material).
Conclusions
The presented work describes the elucidation of the
degradation pathway of the pharmaceutical drug
substance amoxicillin, a commonly used antibiotic
drug. The degradation of amoxicillin was induced by
acidic stress. The degradation products created from
amoxicillin were separated by capillary LC and ana-
lyzed in the first step by an ion trap in the MS,
MS/MS, and MS3 modes. The fragments obtained
were used for the structure elucidation of the degra-
dation products. The identities of the proposed prod-
ucts were confirmed by accurate mass measurement
with ESI oaTOF and empirical formula calculation for
the molecular ions of the degradation products. Ad-
ditionally, a CID experiment was carried out with the
ESI oaTOF instrument by increasing the fragmentor
voltage. In this experiment, the molecular identity of
the fragments, which are derived from the degrada-
tion products of amoxicillin, were confirmed by ac-
curate mass. The same fragments were generated in a
controlled manner in the ion trap experiment and
therefore support the conclusions. With low single
digit ppm mass accuracy on both the molecular ions
and the CID fragments, the elemental compositions of
the amoxicillin degradation products, and thus the
pathway, were confirmed.
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